Boston Scientific Corp (BSX)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	2,343,000	2,161,000	1,826,000	1,735,000	1,649,000	1,427,000	1,456,000	1,295,000	1,199,000	1,069,000	477,000	144,000	-80,000	80,000	668,000	1,123,000	1,518,000	1,627,000	1,632,000	1,640,000
Total assets	US$ in thousands	35,136,000	34,043,000	33,601,000	32,892,000	32,469,000	31,947,000	32,189,000	32,337,000	32,229,000	31,877,000	31,168,000	30,900,000	30,777,000	30,845,000	30,823,000	30,113,000	30,565,000	26,756,000	24,309,000	23,802,000
Operating ROA		6.67%	6.35%	5.43%	5.27%	5.08%	4.47%	4.52%	4.00%	3.72%	3.35%	1.53%	0.47%	-0.26%	0.26%	2.17%	3.73%	4.97%	6.08%	6.71%	6.89%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $2,343,000K ÷ $35,136,000K
= 6.67%

The operating return on assets (ROA) for Boston Scientific Corp. has been relatively stable and positive over the past eight quarters, ranging from 6.00% to 6.88%. This metric indicates the company's ability to generate operating income relative to its total assets. The gradual increase in operating ROA from Q1 2022 to Q4 2023 suggests improving operational efficiency and profitability. Boston Scientific Corp. has been effectively utilizing its assets to generate operating income, which is a positive sign for investors and stakeholders. The consistent performance of operating ROA reflects the company's strong operational performance and management effectiveness in utilizing its assets to generate profits. It will be important to continue monitoring this metric in future quarters to assess the sustainability of Boston Scientific Corp.'s operational efficiency and profitability.